Pfizer Seen Circling Agila With U.S. Drug Shortages

Pfizer Seen Circling Agila With U.S. Drug Shortages

Munshi Ahmed/Bloomberg

The global market for so-called generic steriles may swell to $17 billion by 2020, according to Citigroup Inc., even as a crackdown on manufacturers by U.S. regulators has added to a shortage of injectable drugs.